Akums Drugs (India) Probability of Future Stock Price Finishing Over 672.10
| AKUMS Stock | 672.10 32.00 5.00% |
Akums |
Akums Drugs Target Price Odds to finish over 672.10
The tendency of Akums Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 672.10 | 90 days | 672.10 | under 95 |
Based on a normal probability distribution, the odds of Akums Drugs to move above the current price in 90 days from now is under 95 (This Akums Drugs and probability density function shows the probability of Akums Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Akums Drugs has a beta of 0.25. This suggests as returns on the market go up, Akums Drugs average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Akums Drugs and will be expected to be much smaller as well. Additionally Akums Drugs and has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Akums Drugs Price Density |
| Price |
Predictive Modules for Akums Drugs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Akums Drugs. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Akums Drugs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Akums Drugs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Akums Drugs is not an exception. The market had few large corrections towards the Akums Drugs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Akums Drugs and, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Akums Drugs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.53 | |
β | Beta against Dow Jones | 0.25 | |
σ | Overall volatility | 96.87 | |
Ir | Information ratio | -0.19 |
Akums Drugs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Akums Drugs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Akums Drugs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Akums Drugs generated a negative expected return over the last 90 days | |
| Akums Drugs has high historical volatility and very poor performance | |
| About 83.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Akums Drugs shares hit second upper circuit, reach new high heres why - Business Standard |
Akums Drugs Technical Analysis
Akums Drugs' future price can be derived by breaking down and analyzing its technical indicators over time. Akums Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Akums Drugs and. In general, you should focus on analyzing Akums Stock price patterns and their correlations with different microeconomic environments and drivers.
Akums Drugs Predictive Forecast Models
Akums Drugs' time-series forecasting models is one of many Akums Drugs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Akums Drugs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Akums Drugs
Checking the ongoing alerts about Akums Drugs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Akums Drugs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Akums Drugs generated a negative expected return over the last 90 days | |
| Akums Drugs has high historical volatility and very poor performance | |
| About 83.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Akums Drugs shares hit second upper circuit, reach new high heres why - Business Standard |
Other Information on Investing in Akums Stock
Akums Drugs financial ratios help investors to determine whether Akums Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Akums with respect to the benefits of owning Akums Drugs security.